Serhii Tsiporenko, Larysa Matyucha


The study of the concentration of metalloproteinases, pro- and anti-inflammatory cytokines, lymphocyte activation markers in seminal plasma of men with oligosymptomatic forms of chronic inflammation of the urogenital tract (CIUT), depending on the fertility rate are presented in the article.

Quantitative characteristics in male sperm with different forms of pathospermia were studied for matrix metalloproteinases (MMP) -2 and MMP-9 and their inhibitors - tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2. It was shown, that during chronic inflammation of the urogenital tract of men are shifting levels of cytokine profile, reducing the concentration of metalloproteinase-2, chemokines - fractalkine and regulated by activation, expression and secretion of normal T-cells (RANTES), sharp increase in IL-8, MCP-1 and elevation of the CD25+ / CD95+, indicating that the disturbance of apoptosis of pathological forms generative cells and their accumulation in the sperm.

The ratio of immunological indices IL-2/IL-4, IL-10/IL-12 was calculated and a significant increase in the IL-10/IL-12 index was noted in the group of individuals with elevated levels of hypercapitated form of sperm, and a reduced proportion of this ratio was observed in the microsomatic morphology of sperm. Prolonged inflammation in the genital area accompanied by depletion of the local immune system, resulting in the development of infertility.

Immunocorrection therapy for men with CIUT should take into account the peculiarities of changes in local immunity and be differentiated depending on the prevalence of certain pathological forms of sperm and changes in the cytokine profile of the seminal plasma.


male infertility; sperm; seminal plasma; metalloproteinase; cytokine profile; markers of lymphocyte activation

Full Text:



Orlova, L., Pyetrov, S. (2011). Aktyvnist metaloproteinazy matryksu (ММР-2) I. Katepsynopodibnoyi proteyinazy D u riznych vydiv zmiy. Visnyk Lvivskogo Universytetu, 55, 34–38.

Syed, R., Farukh, R., Shaista, R., Akbar, M., Shajrul, A. (2012). Role of proteases in cancer: A review. Biotechnology and Molecular Biology Reviews, 7 (4), 90–101. doi: 10.5897/bmbr11.027

Radisky, E. S., Radisky, D. C. (2010). Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 15 (2), 201–212. doi: 10.1007/s10911-010-9177-x

Jablonska-Trypuc, A., Matejczyk, M., Rosochacki, S. (2016). Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry, 31, 177–183. doi: 10.3109/14756366.2016.1161620

Lu, P., Takai, K., Weaver, V. M., Werb, Z. (2011). Extracellular Matrix Degradation and Remodeling in Development and Disease. Cold Spring Harbor Perspectives in Biology, 3 (12), a005058. doi: 10.1101/cshperspect.a005058

Brilha, S., Wysoczanski, R., Whittington, A. M., Friedland, J. S., Porter, J. C. (2017). Monocyte Adhesion, Migration, and Extracellular Matrix Breakdown Are Regulated by Integrin αVβ3 inMycobacterium tuberculosisInfection. The Journal of Immunology, 199 (3), 982–991. doi: 10.4049/jimmunol.1700128

Chou, C. H., Teng, C.-M., Tzen, K.-Y., Chang, Y.-C., Chen, J.-H., Cheng, J. C.-H. (2011). MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis. Oncogene, 31 (4), 458–468. doi: 10.1038/onc.2011.240

Song, J., Wu, C., Korpos, E., Zhang, X., Agrawal, S. M., Wang, Y. et. al. (2015). Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration. Cell Reports, 10 (7), 1040–1054. doi: 10.1016/j.celrep.2015.01.037

Newby, A. C., George, S. J., Ismail, Y., Johnson, J. L., Sala-Newby, G. B., Thomas, A. C. (2009). Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thrombosis and Haemostasis, 101 (6), 1006–1011. doi: 10.1160/th08-07-0469

Agere, S. A., Akhtar, N., Watson, J. M., Ahmed, S. (2017). RANTES/CCL5 induces collagen degradation by activating MMP-1 and MMP-13 expression in human rheumatoid arthritis synovial fibroblasts. Frontiers in Immunology, 8, 1341. doi: 10.3389/fimmu.2017.01341

Gounko, N. V., Martens, E., Opdenakker, G., Rybakin, V. (2016). Thymocyte development in the absence of matrix metalloproteinase-9/gelatinase B. Scientific Reports, 6 (1). doi: 10.1038/srep29852

Verma, R. P., Hansch, C. (2007). Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry, 15 (6), 2223–2268. doi: 10.1016/j.bmc.2007.01.011

Fanjul-Fernandez, M., Folgueras, A. R., Cabrera, S., Lopez-Otín, C. (2010). Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research, 1803 (1), 3–19. doi: 10.1016/j.bbamcr.2009.07.004

Cauwe, B., Martens, E., Sagaert, X., Dillen, C., Geurts, N., Li, S. et. al. (2011). Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease. Journal of Autoimmunity, 36 (3-4), 239–252. doi: 10.1016/j.jaut.2011.02.002

Benson, H. L., Mobashery, S., Chang, M., Kheradmand, F., Hong, J. S., Smith, G. N. et. al. (2011). Endogenous Matrix Metalloproteinases 2 and 9 Regulate Activation of CD4+and CD8+T cells. American Journal of Respiratory Cell and Molecular Biology, 44 (5), 700–708. doi: 10.1165/rcmb.2010-0125oc

Sato, W., Tomita, A., Ichikawa, D., Lin, Y., Kishida, H., Miyake, S. et. al. (2012). CCR2+CCR5+ T Cells Produce Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis. The Journal of Immunology, 189 (10), 5057–5065. doi: 10.4049/jimmunol.1202026

Pagemccaw, A. (2008). Remodeling the model organism: Matrix metalloproteinase functions in invertebrates. Seminars in Cell & Developmental Biology, 19 (1), 14–23. doi: 10.1016/j.semcdb.2007.06.004

Mohagheghi, S., Khodadadi, I., Karami, M., Amiri, I., Tavilani, H. (2018). Gene polymorphism of Matrix Metalloproteinase 9 in asthenozoospermic male subjects. International Journal of Fertility & Sterility, 11 (4), 247–252.

Moroz, A., Delella, F. K., Almeida, R., Lacorte, L. M., Favaro, W. J., Deffune, E., Felisbino, S. L. (2013). Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation. PLoS ONE, 8 (12), e84757. doi: 10.1371/journal.pone.0084757

Ayvazova, N. P., Rilcheva, V. S., Konova, E. I., Roussev, R. G., Rashev, P. I. (2016). Original Article. Matrix Metalloproteinase Mmp-2 and Mmp-9 Activities in Seminal Plasma. Journal of Biomedical and Clinical Research, 9 (2). doi: 10.1515/jbcr-2016-0016

Fraczek, M., Kurpisz, M. (2015). Cytokines in the male reproductive tract and their role in infertility disorders. Journal of Reproductive Immunology, 108, 98–104. doi: 10.1016/j.jri.2015.02.001

Lyah, Yu. Ye., Guryanov, V. G. (2004). Osnovy computernoy biostatistiki: analiz informatsii v biologii, meditsinye i farmatsii statistichyeskim pakyetom MedStat. Donetsk, 212.

Hohn, A., Weber, D., Jung, T., Ott, C., Hugo, M., Kochlik, B. et. al. (2017). Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biology, 11, 482–501. doi: 10.1016/j.redox.2016.12.001

Kelly, R. W., Carr, G. G., Critchley, H. O. (1997). A cytokine switch induced by human seminal plasma: an immune modulation with implications for sexually transmitted disease. Human Reproduction, 12 (4), 677–681. doi: 10.1093/humrep/12.4.677

Shuganov, E. G., Raspopina, N. A., Salmasi, Z. M. (2016). Clinical and immunological correlations in chronic obstructive pulmonary disease and bronchial asthma. Almanac of Clinical Medicine, 35, 54–59. doi: 10.18786/2072-0505-2014-35-54-59

Loetscher, P., Clark-Lewis, I. (2001). Agonistic and antagonistic activities of chemokines. Journal of Leukocyte Biology, 69, 881–884.



  • There are currently no refbacks.

Copyright (c) 2018 Serhii Tsiporenko, Larysa Matyucha

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)